Cargando…

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs

INTRODUCTION: Contrasting findings have been published regarding the effect of human immunodeficiency virus (HIV) on tuberculosis (TB) drug pharmacokinetics (PK). OBJECTIVES: The aim of this systematic review was to investigate the effect of HIV infection on the PK of the first-line TB drugs (FLDs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daskapan, Alper, Idrus, Lusiana R., Postma, Maarten J., Wilffert, Bob, Kosterink, Jos G. W., Stienstra, Ymkje, Touw, Daniel J., Andersen, Aase B., Bekker, Adrie, Denti, Paolo, Hemanth Kumar, Agibothu K., Jeremiah, Kidola, Kwara, Awewura, McIlleron, Helen, Meintjes, Graeme, van Oosterhout, Joep J., Ramachandran, Geetha, Rockwood, Neesha, Wilkinson, Robert J., van der Werf, Tjip S., Alffenaar, Jan-Willem C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019645/ https://www.ncbi.nlm.nih.gov/pubmed/30406475 http://dx.doi.org/10.1007/s40262-018-0716-8

Ejemplares similares

Risk factors contributing to a low darunavir plasma concentration
por: Daskapan, Alper, et al.
Publicado: (2017)

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients
por: Rockwood, Neesha, et al.
Publicado: (2016)

Food intake and darunavir plasma concentrations in people living with HIV in an outpatient setting
por: Daskapan, Alper, et al.
Publicado: (2017)

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis
por: Rockwood, Neesha, et al.
Publicado: (2017)

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data
por: Daskapan, Alper, et al.
Publicado: (2019)

Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting
por: van’t Boveneind-Vrubleuskaya, Natasha, et al.
Publicado: (2016)

Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study
por: Ghimire, Samiksha, et al.
Publicado: (2020)

Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania
por: Denti, Paolo, et al.
Publicado: (2015)

Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis
por: Saktiawati, Antonia Morita I., et al.
Publicado: (2019)

Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis
por: Rockwood, Neesha, et al.
Publicado: (2015)

Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children
por: Zhang, C, et al.
Publicado: (2010)

Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review
por: Lawn, Stephen D, et al.
Publicado: (2013)

Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis
por: Schutz, Charlotte, et al.
Publicado: (2020)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis
por: Abdelgawad, Noha, et al.
Publicado: (2022)

Evidence-Based Design of Fixed-Dose Combinations: Principles and Application to Pediatric Anti-Tuberculosis Therapy
por: Svensson, Elin M., et al.
Publicado: (2017)

Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient’s perspective
por: Pradipta, Ivan S., et al.
Publicado: (2021)

Barriers to Optimal Tuberculosis Treatment Services at Community Health Centers: A Qualitative Study From a High Prevalent Tuberculosis Country
por: Pradipta, Ivan S., et al.
Publicado: (2022)

Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial
por: Klis, Sandor, et al.
Publicado: (2014)

Wound Care in Buruli Ulcer Disease in Ghana and Benin
por: Velding, Kristien, et al.
Publicado: (2014)

Sensitivity and specificity of routine diagnostic work-up for tuberculosis in lung clinics in Yogyakarta, Indonesia: a cohort study
por: Saktiawati, Antonia Morita I., et al.
Publicado: (2019)

Utility of Second-Generation Line Probe Assay (Hain MTBDRplus) Directly on 2-Month Sputum Specimens for Monitoring Tuberculosis Treatment Response
por: Rockwood, Neesha, et al.
Publicado: (2017)

Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz
por: Carten, Monica L., et al.
Publicado: (2012)

Population pharmacokinetics of ethambutol in African children: a pooled analysis
por: Tikiso, Tjokosela, et al.
Publicado: (2022)

Current research toward optimizing dosing of first-line antituberculosis treatment
por: McIlleron, Helen, et al.
Publicado: (2018)

Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin‐resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2022)

In-vitro Activity of Avermectins against Mycobacterium ulcerans
por: Omansen, Till F., et al.
Publicado: (2015)

Delayed entry to care by men with HIV infection in Kumasi, Ghana
por: Kumar, Natasha, et al.
Publicado: (2015)

Former Buruli Ulcer Patients’ Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management
por: Velink, Anita, et al.
Publicado: (2016)

Poverty-Related Diseases Attack Simultaneously
por: Thierry Barogui, Yves, et al.
Publicado: (2016)

Quality of interhospital transport of critically ill patients: a prospective audit
por: Ligtenberg, Jack JM, et al.
Publicado: (2005)

Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa
por: Pillai, G, et al.
Publicado: (2013)

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis
por: Wasmann, Roeland E., et al.
Publicado: (2023)

High prevalence of MRSA and ESBL among asylum seekers in the Netherlands
por: Ravensbergen, Sofanne J., et al.
Publicado: (2017)

Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis
por: Ngwalero, Precious, et al.
Publicado: (2021)

Good Quality of Life in Former Buruli Ulcer Patients with Small Lesions: Long-Term Follow-up of the BURULICO Trial
por: Klis, Sandor, et al.
Publicado: (2014)

Practices of therapeutic drug monitoring in tuberculosis: an international survey
por: Margineanu, Ioana, et al.
Publicado: (2022)

Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis
por: Gafar, Fajri, et al.
Publicado: (2023)

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2021)

The usability testing of the integrated electronic healthcare services for diabetes mellitus patients during the pandemic in Indonesia
por: Fitria, Najmiatul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7e7vo02fbu78v7s7q3jujudas7